You are leaving Lundbeck.com/slo
You have chosen to visit another
Lundbeck website or a third-party website, which is provided as a service to you. Lundbeck does not control content on third-party websites and cannot make representations concerning the accuracy of information on every website you visit. Lundbeck is not responsible for the privacy policy of any third-party website. We encourage you to read the privacy policy of every website you visit.
Produkti
Imena in sestavine naših produktov
Lundbeck ima široko paleto zdravil za zdravljenje možganskih bolezni. Z registriranimi zdravili v več kot 100 državah spodbujamo svojo globalno prisotnost po vsem svetu, da lahko inovativne terapije ponudimo ljudem z možganskimi boleznimi.
| Področja zdravljenja | Blagovna znamka | Učinkovine | |
|---|---|---|---|
| Psychosis | Rexulti® | Brexpiprazole | |
| Clopixol® | Zuclopenthixol | ||
| Fluanxol® | Flupentixol | ||
| Depression, Anxiety | Cipralex® | Escitalopram Oxalate | |
| Brintellix® | Vortioxetine | ||
| Depression | Cipramil® | Citalopram | |
| Alzheimer's disease | Ebixa® | Memantine | |
| Schizophrenia | Abilify Maintena® | Aripiprazole | |
| Migraine | Vyepti® | Eptinezumab | |
| Alcohol dependence | Selincro® | Nalmefene |
Več o podjetju Lundbeck
Raziskave in razvoj
Naše bistvo so raziskave in razvoj novih in izboljšanih terapij.
Bolniki
We see patients as people and are committed to support the person behind.
Načrtovani razvoj
Odkrijte naše projekte in učinkovine v razvoju.